Jeffrey Cummings

Determination of covalent binding to intact DNA, RNA, and oligonucleotides by intercalating anticancer drugs using high-performance liquid chromatography. Studies with doxorubicin and NADPH cytochrome P-450 reductase

Jeffrey Cummings, Agnieszka Bartoszek, John F. Smyth · Analytical Biochemistry · 1991 · 34 citations

Medicine, Molecular Biology, Pharmacology +15

Pharmacological and Biochemical Determinants of the Antitumour Activity of the Indoloquinone EO9

Jeffrey Cummings, Victoria J. Spanswick, Alison Ritchie et al. · Biochemical Pharmacology · 1998 · 28 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Determination of mitomycin C, 2,7-diaminomitosene, 1,2-cis- and 1,2-trans-1-hydroxy-2,7-diaminomitosene in tumour tissue by high-performance liquid chromatography

Jeffrey Cummings, Linda Chirrey, N. Willmott et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1993 · 21 citations

Medicine, Oncology, Pharmacology +6

Comparative cardiotoxicity and antitumour activity of doxorubicin (adriamycin) and 4′-deoxydoxorubicin and the relationship to in vivo disposition and metabolism in the target tissues

Jeffrey Cummings, N. Willmott, I. A. R. More et al. · Biochemical Pharmacology · 1987 · 19 citations

Medicine, Pharmacokinetics, Pharmacology +17

Relationship between reductive drug metabolism in tumour tissue of anthracyclines in microspherical form and anti-tumour activity

N. Willmott, Jeffrey Cummings, Elaine Marley et al. · Biochemical Pharmacology · 1990 · 17 citations

Medicine, Oncology, Pharmacology +15